Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tranexamic Acid for Pulmonary Hemorrhage in Cancer Patients
NCT05053867Phase 3Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2022
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in pulmonary hemorrhage, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
pulmonary hemorrhage
Beyond the preview
Go deeper on NCT05053867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05053867.